Literature DB >> 8781145

Detection of anaerobic odontogenic infections by fluorine-18 fluoromisonidazole.

R S Liu1, L S Chu, S H Yen, C P Chang, K L Chou, L C Wu, C W Chang, M T Lui, K Y Chen, S H Yeh.   

Abstract

Odontogenic infections are a potential risk for patients who receive cervicofacial radiotherapy and should be treated before irradiation. Anaerobic microbial infections are the most common causes. This study assessed the value of the hypoxic imaging agent fluorine-18 fluoromisonidazole (FMISO) in detecting anaerobic odontogenic infections. Positron emission tomography (PET) imaging was performed at 2 h after injection of 370 MBq (10 mCi) of FMISO in 26 nasopharyngeal carcinoma patients and six controls with healthy teeth. Tomograms were interpreted visually to identify hypoxic foci in the jaw. All patients received thorough dental examinations as a pre-radiotherapy work-up. Fifty-one sites of periodontitis, 15 periodontal abscesses, 14 sites of dental caries with root canal infection, 23 sites of dental caries without root canal infection, and seven necrotic pulps were found by dental examination. Anaerobic pathogens were isolated from 12 patients. Increased uptake of FMISO was found at 45 out of 51 sites of periodontitis, all 15 sites of periodontal abscess, all 14 sites of dental caries with root canal infection, all seven sites of necrotic pulp and 15 sites of dental caries without obvious evidence of active root canal infection. No abnormal uptake was seen in the healthy teeth of patients or in the six controls. The diagnostic sensitivity, specificity, positive and negative predictive values, and accuracy of FMISO PET scan in detecting odontogenic infections were 93%, 97%, 84%, 99% and 96%, respectively. 18F-fluoride ion bone scan done in three patients showed that 18F-fluoride ion plays no role in the demonstration of anaerobic odontogenic infection. FMISO PET scan is a sensitive method for the detection of anaerobic odontogenic infections, and may play a complementary role in the evaluation of the dental condition of patients with head and neck tumours prior to radiation therapy.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8781145     DOI: 10.1007/bf01367596

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  16 in total

1.  Imaging of hypoxia in human tumors with [F-18]fluoromisonidazole.

Authors:  W J Koh; J S Rasey; M L Evans; J R Grierson; T K Lewellen; M M Graham; K A Krohn; T W Griffin
Journal:  Int J Radiat Oncol Biol Phys       Date:  1992       Impact factor: 7.038

2.  Anaerobic bacteria. Their role in infection and their management.

Authors:  S M Finegold
Journal:  Postgrad Med       Date:  1987-06       Impact factor: 3.840

3.  Occult dental infection as a cause of fever of obscure origin.

Authors:  S L Levinson; J A Barondess
Journal:  Am J Med       Date:  1979-03       Impact factor: 4.965

4.  The action of metronidazole on DNA.

Authors:  D I Edwards
Journal:  J Antimicrob Chemother       Date:  1977-01       Impact factor: 5.790

5.  A comparative study of the effectiveness of metronidazole and penicillin V in eliminating anaerobes from postextraction bacteremias.

Authors:  T W Head; K C Bentley; E P Millar; J A deVries
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1984-08

6.  Radiation necrosis of the mandible: a 10 year study. Part I. Factors influencing the onset of necrosis.

Authors:  C G Murray; J Herson; T E Daly; S Zimmerman
Journal:  Int J Radiat Oncol Biol Phys       Date:  1980-05       Impact factor: 7.038

7.  Electron-affinic sensitization. VII. A correlation between structures, one-electron reduction potentials, and efficiencies of nitroimidazoles as hypoxic cell radiosensitizers.

Authors:  G E Adams; I R Flockhart; C E Smithen; I J Stratford; P Wardman; M E Watts
Journal:  Radiat Res       Date:  1976-07       Impact factor: 2.841

8.  Tumor radioresistance in clinical radiotherapy.

Authors:  L J Peters; H R Withers; H D Thames; G H Fletcher
Journal:  Int J Radiat Oncol Biol Phys       Date:  1982-01       Impact factor: 7.038

Review 9.  Metronidazole in anaerobic infections: a review of its activity, pharmacokinetics and therapeutic use.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1978-11       Impact factor: 9.546

10.  Comparative susceptibilities of anaerobic bacteria to metronidazole, ornidazole, and SC-28538.

Authors:  E J Goldstein; V L Sutter; S M Finegold
Journal:  Antimicrob Agents Chemother       Date:  1978-10       Impact factor: 5.191

View more
  4 in total

Review 1.  Hypoxia imaging-directed radiation treatment planning.

Authors:  J G Rajendran; K R G Hendrickson; A M Spence; M Muzi; K A Krohn; D A Mankoff
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-07       Impact factor: 9.236

Review 2.  Positron emission tomography to assess hypoxia and perfusion in lung cancer.

Authors:  Eline E Verwer; Ronald Boellaard; Astrid Am van der Veldt
Journal:  World J Clin Oncol       Date:  2014-12-10

3.  Preclinical validation of the hypoxia tracer 2-(2-nitroimidazol-1-yl)- N-(3,3,3-[(18)F]trifluoropropyl)acetamide, [(18)F]EF3.

Authors:  P Mahy; M De Bast; P H Leveque; J Gillart; D Labar; J Marchand; V Gregoire
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-06-10       Impact factor: 9.236

4.  Imaging latent tuberculosis infection with radiolabeled nitroimidazoles.

Authors:  Alfred O Ankrah; Andor W J M Glaudemans; Mike M Sathekge; Hans C Klein
Journal:  Clin Transl Imaging       Date:  2016-03-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.